BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26138589)

  • 1. Generation of α-1,3-Galactosyltransferase-Deficient Porcine Embryonic Fibroblasts by CRISPR/Cas9-Mediated Knock-in of a Small Mutated Sequence and a Targeted Toxin-Based Selection System.
    Sato M; Kagoshima A; Saitoh I; Inada E; Miyoshi K; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
    Reprod Domest Anim; 2015 Oct; 50(5):872-80. PubMed ID: 26138589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combinational use of CRISPR/Cas9-based gene editing and targeted toxin technology enables efficient biallelic knockout of the α-1,3-galactosyltransferase gene in porcine embryonic fibroblasts.
    Sato M; Miyoshi K; Nagao Y; Nishi Y; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
    Xenotransplantation; 2014; 21(3):291-300. PubMed ID: 24919525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient generation of GGTA1-deficient pigs by electroporation of the CRISPR/Cas9 system into in vitro-fertilized zygotes.
    Tanihara F; Hirata M; Nguyen NT; Sawamoto O; Kikuchi T; Doi M; Otoi T
    BMC Biotechnol; 2020 Aug; 20(1):40. PubMed ID: 32811500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Generation of Somatic Cell Nuclear Transfer-Competent Porcine Cells with Mutated Alleles at Multiple Target Loci by Using CRISPR/Cas9 Combined with Targeted Toxin-Based Selection System.
    Sato M; Miyoshi K; Nakamura S; Ohtsuka M; Sakurai T; Watanabe S; Kawaguchi H; Tanimoto A
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient production of biallelic GGTA1 knockout pigs by cytoplasmic microinjection of CRISPR/Cas9 into zygotes.
    Petersen B; Frenzel A; Lucas-Hahn A; Herrmann D; Hassel P; Klein S; Ziegler M; Hadeler KG; Niemann H
    Xenotransplantation; 2016 Sep; 23(5):338-46. PubMed ID: 27610605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient generation of targeted and controlled mutational events in porcine cells using nuclease-directed homologous recombination.
    Butler JR; Santos RMN; Martens GR; Ladowski JM; Wang ZY; Li P; Tector M; Tector AJ
    J Surg Res; 2017 May; 212():238-245. PubMed ID: 28550913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of α1,3-galactosyltransferase and cytidine monophosphate-N-acetylneuraminic acid hydroxylase gene double-deficient pigs by CRISPR/Cas9 and handmade cloning.
    Gao H; Zhao C; Xiang X; Li Y; Zhao Y; Li Z; Pan D; Dai Y; Hara H; Cooper DK; Cai Z; Mou L
    J Reprod Dev; 2017 Feb; 63(1):17-26. PubMed ID: 27725344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of B cell-deficient pigs by highly efficient CRISPR/Cas9-mediated gene targeting.
    Chen F; Wang Y; Yuan Y; Zhang W; Ren Z; Jin Y; Liu X; Xiong Q; Chen Q; Zhang M; Li X; Zhao L; Li Z; Wu Z; Zhang Y; Hu F; Huang J; Li R; Dai Y
    J Genet Genomics; 2015 Aug; 42(8):437-44. PubMed ID: 26336800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
    Auer TO; Del Bene F
    Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A desirable transgenic strategy using GGTA1 endogenous promoter-mediated knock-in for xenotransplantation model.
    Ko N; Shim J; Kim HJ; Lee Y; Park JK; Kwak K; Lee JW; Jin DI; Kim H; Choi K
    Sci Rep; 2022 Jun; 12(1):9611. PubMed ID: 35688851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing the porcine iGb3s gene does not affect Galα3Gal levels or measures of anticipated pig-to-human and pig-to-primate acute rejection.
    Butler JR; Skill NJ; Priestman DL; Platt FM; Li P; Estrada JL; Martens GR; Ladowski JM; Tector M; Tector AJ
    Xenotransplantation; 2016 Mar; 23(2):106-16. PubMed ID: 27106872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.
    Bierle CJ; Anderholm KM; Wang JB; McVoy MA; Schleiss MR
    J Virol; 2016 Aug; 90(15):6989-6998. PubMed ID: 27226370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical method for targeted disruption of cilia-related genes by using CRISPR/Cas9-mediated, homology-independent knock-in system.
    Katoh Y; Michisaka S; Nozaki S; Funabashi T; Hirano T; Takei R; Nakayama K
    Mol Biol Cell; 2017 Apr; 28(7):898-906. PubMed ID: 28179459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome engineering using CRISPR-Cas9 system.
    Cong L; Zhang F
    Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes.
    Yoshimi K; Kunihiro Y; Kaneko T; Nagahora H; Voigt B; Mashimo T
    Nat Commun; 2016 Jan; 7():10431. PubMed ID: 26786405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna.
    Kumagai H; Nakanishi T; Matsuura T; Kato Y; Watanabe H
    PLoS One; 2017; 12(10):e0186112. PubMed ID: 29045453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
    Zhang Y; Huang H; Zhang B; Lin S
    Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of GGTA1 Mutant Pigs by Direct Pronuclear Microinjection of CRISPR/Cas9 Plasmid Vectors.
    Chuang CK; Chen CH; Huang CL; Su YH; Peng SH; Lin TY; Tai HC; Yang TS; Tu CF
    Anim Biotechnol; 2017 Jul; 28(3):174-181. PubMed ID: 27834588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones.
    Watanabe S; Sakurai T; Nakamura S; Miyoshi K; Sato M
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion of homologous DNA in nuclease-mediated gene targeting facilitates a higher incidence of bi-allelically modified cells.
    Beaton BP; Kwon DN; Choi YJ; Kim JH; Samuel MS; Benne JA; Wells KD; Lee K; Kim JH; Prather RS
    Xenotransplantation; 2015; 22(5):379-90. PubMed ID: 26381494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.